Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs developed initially for treatment of type 2 diabetes (T2D) and then obesity, by mimicking the incretin effect which includes glucose-dependent increased insulin secretion and improved glycaemic control, and inducing weight loss in a dose-dependent manner [1]
Personalized care is crucial to evaluate health conditions, potential side effects, and individual goals
Only with healthcare approval
This activity is instrumental in safeguarding hippocampal neurons from the deleterious impacts of glutamate-induced excitotoxicity and hypoxic conditions
Schwarzer, G., Carpenter, J
US$ 20.17
US$ 22.40
US$ 29.25
US$ 24.57
US$ 22.94
US$ 29.72
US$ 26.61
US$ 28.26
